Results 181 to 190 of about 213,106 (383)

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher, Felix Lindberg, Lina Benson, Camilla Hage, Ulf Dahlström, Stephan Rosenkranz, Francesco Cosentino, Giuseppe M.C. Rosano, Stefan Blankenberg, Paulus Kirchhof, Frieder Braunschweig, Lars H. Lund, Gianluigi Savarese   +12 more
wiley   +1 more source

The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements [PDF]

, 2005
Carsten Tschöpe, Mario Kašner, Dirk Westermann, Regina Gaub, Wolfgang Poller, Heinz-Peter Schultheiß   +5 more
openalex   +1 more source

eGFR slope as predictor of mortality in heart failure patients

ESC Heart Failure, Volume 12, Issue 2, Page 1217-1226, April 2025.
Abstract Aims Heart failure (HF) leads to an imbalance between heart and kidney function, resulting in poor outcomes. However, the prognostic significance of the estimated glomerular filtration rate (eGFR) trajectory in HF patients remains unclear. We analysed electronic health records (EHRs) of real‐world HF patients, assessing eGFR trajectories and ...
Sofie Verstreken, Monika Beles, Clara L. Oeste, Ana Moya, Imke Masuy, Riet Dierckx, Ward Heggermont, Jeroen Dauw, Dries Hens, Jozef Bartunek, Marc Vanderheyden   +10 more
wiley   +1 more source

Adropin Predicts Asymptomatic Heart Failure in Patients with Type 2 Diabetes Mellitus Independent of the Levels of Natriuretic Peptides

Diagnostics
In patients with type 2 diabetes mellitus (T2DM), asymptomatic adverse cardiac remodeling plays a pivotal role in the development of heart failure (HF). Patients with T2DM often have low or near-normal levels of natriuretic peptides, including N-terminal
Tetiana A. Berezina, Oleksandr O. Berezin, Uta C. Hoppe, Michael Lichtenauer, Alexander E. Berezin   +4 more
doaj   +1 more source

280 NT-proBNP level and LV function in patients with acute anterior MI treated with primary PCI [PDF]

, 2005
Z. Tabor, Jarosław Myszor, Artur Filipecki, D. Urbanczyk, Maciej Turski, W. Orszulak, K. Wila, Maria Trusz‐Gluza   +7 more
openalex   +1 more source

Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization

ESC Heart Failure, Volume 12, Issue 2, Page 1227-1236, April 2025.
Comparative performance of 7 risk prediction indices in patients hospitalized for heart failure. In this cohort of 1206 patients, the LENT index offered the greatest discrimination, calibration, and overall accuracy in predicting 30‐day composite all‐cause mortality or readmission following hospitalization for heart failure.
Tauben Averbuch, Ali Zafari, Shofiqul Islam, Shun Fu Lee, Rajiv Sankaranarayanan, Stephen J Greene, Mamas A Mamas, Ambarish Pandey, Harriette GC Van Spall   +8 more
wiley   +1 more source

262 Changes in ultrasound lung comets as a guide to treatment in heart failure patients: correlation with NT-proBNP [PDF]

, 2005
Elisa Poggianti, Suzana Gligorova, Francesca Frassi, Marco Agrusta, Luna Gargani, Michele Emdin, Gaetano Mottola, Eugenio Picaño   +7 more
openalex   +1 more source

Projecting the benefit of vericiguat in PARADIGM‐HF and DAPA‐HF populations: Insights from the VICTORIA trial

ESC Heart Failure, Volume 12, Issue 2, Page 1479-1484, April 2025.
Abstract Aims The VICTORIA trial demonstrated a significant reduction in the primary composite outcome of heart failure (HF) hospitalization or cardiovascular death with vericiguat relative to placebo in high‐risk HF. This study aimed to contextualize treatment effects of vericiguat in populations with varying risk profiles simulated from the PARADIGM ...
Veraprapas Kittipibul, Robert J. Mentz, Rebecca Young, Javed Butler, Justin A. Ezekowitz, Carolyn S.P. Lam, Piotr Ponikowski, Adriaan Voors, Stefano Corda, Ciaran McMullan, Christopher M. O'Connor, Kevin J. Anstrom, Paul W. Armstrong, for the VICTORIA Study Group   +13 more
wiley   +1 more source

New horizons: NT-proBNP for risk stratification of patients with shock in the intensive care unit. [PDF]

, 2006
Ursula Hoffmann, Martin Borggrefe, Martina Brueckmann   +2 more
openalex   +1 more source

Ремоделювання серцево-судинної системи та рівень мозкового натрійуретричного пептиду у хворих на артеріальну гіпертензію [PDF]

, 2013
У 363 хворих на гіпертонічну хворобу (ГХ) ІІ стадії співставленні дані ремоделювання серцево-судинної системи та рівня метаболіту мозкового натрійуретичного пептиду Nt-proBNP.
Доценко, С.Я.
core